Monthly Production Of Covishield, Covaxin Planned To Be Increased: Centre

COVID-19 Vaccines India: Elaborating on the steps taken to increase the production of COVID-19 vaccines in the country, Minister of State for Health Bharati Pravin Pawar said Central Drugs Standard Control Organisation has taken various steps for fast track approval of vaccines.

The monthly vaccine production capacity of Covishield is planned to be increased from 11 crore doses to more than 12 crore doses per month and of Covaxin from 2.5 crore doses to around 5.8 crore, the Lok Sabha was informed on Friday. From January 16 to August 5, 44.42 crore doses of Covishield were supplied by Serum Institute of India and 6.82 crore doses of Covaxin by Bharat Biotech for the National COVID-19 Vaccination Programme, Minister of State for Health Bharati Pravin Pawar said in a written reply. "As communicated by the manufacturers, the monthly vaccine production capacity of Covishield is planned to be increased from 11 crore doses per month to more than 12 crore doses per month and the production capacity of Covaxin is planned to be increased from 2.5 crore doses per month to around 5.8 crore doses per month," she said in response to a question on the total capacity of vaccine manufacturing or production in the country. Elaborating on the steps taken to increase the production of COVID-19 vaccines in the country, Ms Pawar said Central Drugs Standard Control Organisation has taken various steps for fast track approval of vaccines.